Literature DB >> 8090056

The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung.

I M Adcock1, H Shirasaki, C M Gelder, M J Peters, C R Brown, P J Barnes.   

Abstract

Glucocorticoids have a wide variety of effects which result in the dampening of inflammatory and immune responses and other challenges to homeostasis. An important site of steroid action may be on the control of transcription factor binding to DNA. The interaction of the transcription factors, activator protein 1 (AP-1) and nuclear factor kappa from B cells (NF kappa B) with DNA and glucocorticoid receptors was analysed by gel mobility shift assays following stimulation by tumour necrosis factor alpha (TNF alpha) and a phorbol ester (PMA) that activates protein kinase C. PMA and TNF alpha both caused significant (180-340%) increases in AP-1 and NF kappa B DNA binding which peaked at 15 minutes and decreased to a constant elevated level at between 1-3 hrs and was sustained for 24hrs. Dexamethasone (1 microM) caused a rapid and long lasting 40-50% decrease in both AP-1 and NF kappa B DNA binding lasting over 24hrs. Combined treatment with dexamethasone and PMA or TNF alpha prevented the increase in both AP-1 and NF kappa B binding due to PMA and TNF alpha returning levels to those seen in control untreated samples. This suggests that in human lung, the glucocorticoid receptor functionally interacts within the nucleus with other transcription factors that are induced by inflammatory mediators such as cytokines. This may be an important molecular site of steroid action in chronic inflammatory lung diseases such as asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090056     DOI: 10.1016/0024-3205(94)00243-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Interactions between corticosteroids and beta agonists.

Authors:  D R Taylor; R J Hancox
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Effects of high-dose corticosteroids on post-traumatic inflammatory mediators.

Authors:  Olav Reikerås; Arthur Helle; Claus Danckert Krohn; Jens Ivar Brox
Journal:  Inflamm Res       Date:  2009-06-28       Impact factor: 4.575

3.  Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.

Authors:  R J Hancox; D A Stevens; I M Adcock; P J Barnes; D R Taylor
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

4.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells.

Authors:  Daphne C Tsitoura; Paul B Rothman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

6.  Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

Authors:  I M Adcock; S J Lane; C R Brown; T H Lee; P J Barnes
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

7.  Differential response to dexamethasone on the TXB2 release in guinea-pig alveolar macrophages induced by zymosan and cytokines.

Authors:  M E Salgueiro; M Conde; A J Seco; N Méndez; G Manso
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

8.  The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia.

Authors:  Xinhong Guo; Halida Yasen; Fang Zhao; Lei Wang; Mingling Sun; Nannan Pang; Xiujuan Wang; Ying Zhang; Jianbing Ding; Xiumin Ma
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.